Fund Holdings — Pivotal bioVenture Partners Investment Advisor LLC

Total Portfolio Value:
$123.56M
Total Bought:
$45.02M
Total Sold:
$0
Net Transaction:
+$45.02M
Notable People:
Robert Lorne Hopfner, Peter Tuxen Bisgaard, Pivotal Bioventure Partners, Pivotal Partners Ltd
Securities
▲▼
SharesValue
Q4 2024
▲▼
Q1 2025
▲▼
Change
▲▼
Q4 2024
▲▼
Q1 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Oculis Holding AG(OCS)1,737,6962,300,774+563,078$29.54M$43.78M35.43%+$14.24M
Arcutis Biotherapeutics, Inc.(ARQT)2,120,5082,120,5080$29.54M$33.16M26.84%+$3.63M
Vaxcyte, Inc.(PCVX)703,834710,734+6,900$57.62M$26.84M21.72%-$30.78M
Zenas BioPharma, Inc.(ZBIO)736,645736,6450$6.03M$5.82M4.71%-$213.6K
Inozyme Pharma Inc4,494,8514,494,8510$12.45M$4.09M3.31%-$8.36M
Recursion Pharmaceuticals, Inc.CL A(RXRX)595,518595,5180$4.03M$3.15M2.55%-$875.4K
BioAge Labs, Inc.(BIOA)653,374653,3740$3.78M$2.46M1.99%-$1.33M
Rallybio Corporation(RLYB)2,404,6442,404,6440$2.31M$1.56M1.26%-$745.4K
Vigil Neuroscience Inc560,595560,5950$953.0K$997.9K0.81%+$44.8K
Io Biotech Inc864,197864,1970$795.1K$942.0K0.76%+$146.9K
Bolt Biotherapeutics Inc1,891,4671,891,4670$1.02M$756.6K0.61%-$264.8K
Page 1 of 1